By The Defender Staff A pharmaceutical industry whistleblower warned that Ozempic, the new diabetes and obesity drug sold by Novo Nordisk, poses a potential safety “disaster.” Calley…
By The Defender Staff A pharmaceutical industry whistleblower warned that Ozempic, the new diabetes and obesity drug sold by Novo Nordisk, poses a potential safety “disaster.” Calley…